Michael Law

Mike

Faculty, Centre for Health Services and Policy Research
Canada Research Chair in Access to Medicines
Professor, UBC School of Population and Public Health

michael.law@ubc.ca
(604) 822-3514


Profile

Dr. Michael Law holds the Canada Research Chair in Access to Medicines, and is a professor in the Centre for Health Services and Policy Research, School of Population and Public Health, at the University of British Columbia.

Michael’s research program focuses on pharmaceutical policy. His work focuses on access to and the use of prescription drugs, including the affordability of prescription drugs, private drug insurance, generic drug pricing, and the impact of pharmacist prescribing. His research program has attracted more than $2.5 million in research funding, including 4 operating grants from CIHR as principal investigator. Currently, his program of research includes studies in several countries, including Canada, Rwanda, Uganda, Namibia, and Colombia.

He has been published in leading medical journals, including BMJ, Archives of Internal Medicine, and CMAJ. This work has been featured in news media such as New Scientist, Forbes, the Globe & Mail, and USA Today. He has also authored commentaries that have appeared in the Toronto Star and Vancouver Sun. His research has had a major impact on generic drug pricing in Canada, leading to policy changes that have saved governments the country more than $100 million every year.

Since his appointment at UBC he has received several notable awards, including a Canada Research Chair (2015), a Distinguished Achievement Award from the UBC Faculty of Medicine (2012), the Labelle Lectureship at McMaster University, the 2011 Paper of the Year Award from the CIHR Institute for Health Services and Policy Research, a Canadian Institutes of Health Research New Investigator Award, and a Michael Smith Foundation for Health Research Scholar Award.

In 2015, he taught one of UBC’s first edX.org Professional Education courses on Interrupted Time Series Analysis.

Prior to joining UBC, he completed a PhD in Health Policy at Harvard University and a post-doctoral fellowship at Harvard Medical School, where he trained in research methods and statistics. He has also completed an MSc from the London School of Economics, and worked as a research associate at the University of Auckland, New Zealand.

Education

PhD, Health Policy, Harvard University, 2008
MSc, Health Population and Society, London School of Economics, 2002
BA&Sc, Arts & Sciences Program, McMaster University, 2001

Research Interests

  • Pharmaceutical policy
  • Observational studies
  • Medication adherence and health outcomes
  • Routine data in lower-income countries

Current Projects

  • Cost-related nonadherence to prescription drugs: A multi-method study
  • Impact of physician detailing and sampling for generic atorvastatin

Affiliations and Awards

  • Career Investigator Scholar Award, Michael Smith Foundation for Health Research, 2012-2020
  • New Investigator Award, CIHR, 2010-2015

Current Graduate Students

  • Alexandra Lukey, PhD Student, School of Population and Public Health
  • Jean Makuza, PhD Student, School of Population and Public Health
  • Richard Musoke, PhD Student, School of Population and Public Health
  • Maryann Rogers, MSc Student, School of Population and Public Health
  • Hinda Ruton, PhD Student, School of Population and Public Health

Courses Currently Taught


Recent Publications

Wickham ME, McGrail KM, Law MR, Cragg A, Hohl CM. Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug events. Br J Clin Pharmacol. 2024 Apr 11. doi: 10.1111/bcp.16067. Online ahead of print. Read more

Au SW, Law MR, Cheng L, McGrail K, Harrison M. The Impact of reference pricing on prescribing patterns, costs, and health services utilization of proton pump inhibitors: A quasi-experimental study in British Columbia, Canada. Health Policy. 2024 Apr 4;144:105061. doi: 10.1016/j.healthpol.2024.105061. Online ahead of print. Read more

Trenaman L, Guh D, Law MR, Cheng L, Harrison M. Effect of a billing code to reimburse nurse-supported rheumatology care on health care costs and access: an interrupted time series analysis. Arthritis Care Res (Hoboken). 2024 Feb 25. doi: 10.1002/acr.25317. Online ahead of print. Read more

Law M, Clement F. National Pharmacare: Laying the Groundwork. IRPP Insight No. 51. Montreal: Institute for Research on Public Policy; February 2024. Read more

Wickham ME, McGrail KM, Law MR, Cragg A, Hohl CM. Validating methods used to identify non-adherence adverse drug events in Canadian administrative health data. Br J Clin Pharmacol. 2024 Feb 6. doi: 10.1111/bcp.16014. Online ahead of print. Read more

Zeitouny S, McGrail K, Tadrous M, Wong ST, Cheng L, Law M. Impact of the COVID-19 pandemic on prescription drug use and costs in British Columbia: a retrospective interrupted time series study. BMJ Open. 2024 Jan 4;14(1):e070031. doi: 10.1136/bmjopen-2022-070031. Read more

Rebić N, Law MR, Brotto LA, Cragg JJ, De Vera MA. The Intersectional Impact of Cost-Related Non-Adherence and Depression: A Cross-Sectional Analysis of the Canadian Community Health Survey by Sex, Race, and Indigeneity. Community Ment Health J. 2023 Nov 6. doi: 10.1007/s10597-023-01202-1. Online ahead of print. Read more

Johnson KM, Cheng L, Yin Y, Carter R, Chow S, Brigham E, Law MR. Impact of income-based public drug coverage deductibles on adherence to asthma medications. Ann Allergy Asthma Immunol. 2023 Oct 21:S1081-1206(23)01345-5. doi: 10.1016/j.anai.2023.10.017. Online ahead of print. Read more

Itiola AJ, Cheng L, Zhang W, Gomes T, Shah BR, Law MR. The Impact of Blood Glucose Test Strips Reimbursement Limits on Utilization, Costs, and Health Care Use in British Columbia. Can J Diabetes. 2023 Aug 21:S1499-2671(23)00193-4. doi: 10.1016/j.jcjd.2023.08.005. Online ahead of print. Read more

Zeitouny S, Cheng L, Wong ST, Tadrous M, McGrail K, Law MR. Prevalence and predictors of primary nonadherence to medications prescribed in primary care. CMAJ. 2023 Aug 8;195(30):E1000-E1009. doi: 10.1503/cmaj.221018. Read more

Cui Z, Karamouzian M, Law M, Hayashi K, Milloy MJ, Kerr T. The Impact of Longitudinal Substance Use Patterns on the Risk of Opioid Agonist Therapy Discontinuation: A Repeated Measures Latent Class Analysis. Int J Ment Health Addict. 2023 Jun. https://doi.org/10.1007/s11469-023-01098-8. Read more

Romanowski K, Law MR, Karim ME, Campbell JR, Hossain MB, Gilbert M, Cook VJ, Johnston JC. Healthcare utilization after respiratory tuberculosis: a controlled interrupted time series analysis. Clin Infect Dis. 2023 May 9:ciad290. doi: 10.1093/cid/ciad290. Online ahead of print. Read more

Persaud N, Bedard M, Boozary A, Glazier RH, Gomes T, Hwang SW, Jüni P, Law MR, Mamdani M, Manns B, Martin D, Morgan SG, Oh P, Pinto AD, Shah BR, Sullivan F, Umali N, Thorpe KE, Tu K, Wu F, Laupacis A; CLEAN Meds study team. Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial. JAMA Health Forum. 2023 May 5;4(5):e231127. doi: 10.1001/jamahealthforum.2023.1127. Read more

Rebić N, Law MR, Cragg J, Brotto LA, Ellis U, Garg R, Park JY, De Vera MA. "What's sex and gender got to do with it?" A scoping review of sex and gender-based analysis in pharmacoepidemiologic studies of medication adherence. Value Health. 2023 Apr 15:S1098-3015(23)02559-7. doi: 10.1016/j.jval.2023.04.002. Online ahead of print. Read more

Morrow RL, Mintzes B, Gray G, Law MR, Garrison S, Dormuth CR. Public reporting of clinical trial findings as an ethical responsibility to participants: a qualitative study. BMJ Open. 2023 Mar 21;13(3):e068221. doi: 10.1136/bmjopen-2022-068221. Read more

Older publications